BRADLEY PHARMACEUTICALS INC
SC 13G/A, 1997-02-04
PHARMACEUTICAL PREPARATIONS
Previous: L M CAPITAL INC, 8-K, 1997-02-04
Next: LUNAR CORP, SC 13G/A, 1997-02-04










                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13G

                    Under the Securities Exchange Act of 1934
                          (Amendment No.____4_______)*


                      Bradley Pharmaceuticals, Inc.
              -----------------------------------------------------
                                (Name of Issuer)

                      Class A Common Stock, no par value
          -------------------------------------------------------------
                         (Title of Class of Securities)

                                    104576103
              -----------------------------------------------------
                                 (CUSIP Number)



Check the following box if a fee is  being paid with this statement [ ].

(A fee is not required only if the filing person:  (1) has a previous  statement
on file reporting beneficial ownership of more than five percent of the class of
securities  described  in Item 1;  and (2) has  filed  no  amendment  subsequent
thereto reporting  beneficial  ownership of five percent or less of such class.)
(See Rule 13d-7.)

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for any  subsequent  amendment  containing  information  which  would  alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).

                 


<PAGE>

CUSIP No. 104576103                   13G                    Page 2 of 5 Pages



- - - --------------------------------------------------------------------------------
   1   NAME OF REPORTING PERSON
       S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

       J. Morton Davis
        

- - - --------------------------------------------------------------------------------
   2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                             (a)  [  ]
                                                             (b)  [  ]


- - - --------------------------------------------------------------------------------
   3   SEC USE ONLY




- - - --------------------------------------------------------------------------------
   4   CITIZENSHIP OR PLACE OF ORGANIZATION


       United States

- - - --------------------------------------------------------------------------------
   NUMBER OF      5    SOLE VOTING POWER
     SHARES            279,200
  BENEFICIALLY    --------------------------------------------------------------
    OWNED BY      6    SHARED VOTING POWER
      EACH             0
   REPORTING      --------------------------------------------------------------
     PERSON       7    SOLE DISPOSITIVE POWER
      WITH             279,200
                  --------------------------------------------------------------
                  8    SHARED DISPOSITIVE POWER
                       0
- - - --------------------------------------------------------------------------------
   9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON


                      279,200
- - - --------------------------------------------------------------------------------
  10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*



- - - --------------------------------------------------------------------------------
  11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)


                       3.8%
- - - --------------------------------------------------------------------------------
  12   TYPE OF REPORTING PERSON*



                      IN
- - - --------------------------------------------------------------------------------
                     *SEE INSTRUCTIONS BEFORE FILLING OUT


<PAGE>

CUSIP No. 104576103                   13G                    Page 3 of 5 Pages


- - - --------------------------------------------------------------------------------
   1   NAME OF REPORTING PERSON
       S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

       D.H. Blair Investment Banking Corp.
       

- - - --------------------------------------------------------------------------------
   2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                             (a)  [  ]
                                                             (b)  [  ]


- - - --------------------------------------------------------------------------------
   3   SEC USE ONLY




- - - --------------------------------------------------------------------------------
   4   CITIZENSHIP OR PLACE OF ORGANIZATION


       Delaware

- - - --------------------------------------------------------------------------------
   NUMBER OF      5    SOLE VOTING POWER
     SHARES            0
  BENEFICIALLY    --------------------------------------------------------------
    OWNED BY      6    SHARED VOTING POWER
      EACH             243,200
   REPORTING      --------------------------------------------------------------
     PERSON       7    SOLE DISPOSITIVE POWER
      WITH             0
                  --------------------------------------------------------------
                  8    SHARED DISPOSITIVE POWER

                       243,200
- - - ----------------------------------------------------------------------------
   9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                        243,200

- - - --------------------------------------------------------------------------------
  10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*



- - - --------------------------------------------------------------------------------
  11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)


                       3.3%
- - - --------------------------------------------------------------------------------
  12   TYPE OF REPORTING PERSON*
                     BD
- - - --------------------------------------------------------------------------------
                     *SEE INSTRUCTIONS BEFORE FILLING OUT

<PAGE>
                                                         Page 4 of 5 Pages


Item 1.        J. Morton Davis and D.H. Blair Investment Banking Corp. 
               ("Blair Investment") (together, the "Reporting Parties"), 
               hereby amend their statement on Schedule 13G relating to the 
               Class A Common Stock, no par value ("shares") of Bradley 
               Pharmaceuticals, Inc. (the "Issuer") as follows:



Item 2. (a) is hereby amended in its entirety as follows:

               J. Morton  Davis  and Blair  Investment  (1). See Exhibit A
               which  is a copy of  their  agreement  in  writing  to file  this
               statement  on  behalf  of  each of them  (previously  filed  in 
               Schedule 13G, Amendment No. 3, dated February 14, 1996, of which 
               this is Amendment No. 4 thereto, and incorporated by reference
               herein).

Item 2. (b) is hereby amended in its entirety as follows:

               Mr. Davis' and Blair Investment's business address is 44 Wall 
               Street, New York, New York  10005.

Item 2. (c) is hereby amended in its entirety as follows:

               Mr. Davis is a United States citizen.  Blair Investment is 
               incorporated in the State of Delaware. 

Item 4. is hereby amended in its entiretly as follows:

       (a) (b) As of December 31, 1996,  Mr. Davis may be deemed to
               beneficially  own 279,200 shares or 3.8% of the Issuer's  shares.
               Of these  shares,  (i) 36,000  shares  underlie  a Unit  Purchase
               Option to purchase 1 Unit (2) at $45,000 per Unit owned  directly
               by Mr. Davis and  exercisable  through  December  10, 1998;  (ii)
               235,800 shares underlying a Unit Purchase Option to purchase 6.55
               Units (2) at $45,000 per Unit owned directly by Blair  Investment
               exercisable  through  December 10,  1998;  and (iii) 7,400 shares
               owned directly by Blair Investment.

               As of December 31, 1996,  Blair  Investment may be deemed to
               beneficially  own 243,200  shares or 3.3% as  indicated in (ii) 
               and (iii) above.

          (c)  Mr.  Davis  has sole  power to vote or to  direct  the  vote,  to
               dispose or to direct the  disposition  of those  shares  owned by
               Blair  Investment.  

Item 5. is hereby amended in its entirety as follows:

               As of  November 12, 1996, Mr. Davis and Blair  Investment  have
               ceased to be  beneficial  owners of more than five percent of the
               Issuer's securities. 

- - - ------------------------------------------------------------------------------

(1) Mr.  Davis  is an  investment  banker  and  sole  shareholder  of Blair
Investment,  a  broker-dealer  registered  under the Securities  Exchange Act of
1934. Prior to May 1, 1996,  Blair Investment was a wholely-owned subsidiary of
D.H. Blair Holdings, Inc. ("Blair Holdings"), which was solely owned by Mr. 
Davis.   As of May 1, 1996, Blair Holdings merged into Blair Investment, with
Blair Investment being the surviving corporation.

(2) Each Unit consists of 24,000 shares and 12,000 Class D Warrants.  Each 
Class D Warrant is exercisable to purchase one share at an exercise price of
$3.00 through December 10, 1998.

<PAGE>
                                                         Page 5 of 5 Pages

                                   Signature.


            After reasonable inquiry and to the best of my knowledge and belief,
            we certify that the information set forth in this statement is true,
            complete and correct.


Date: February 3, 1997
      

By: /s/ J. Morton Davis
   -------------------------------
    J. Morton Davis






Date: February 3, 1997

      D.H. Blair Investment Banking Corp.



By:  /s/ David Nachamie
   -------------------------------
     David Nachamie
     Treasurer



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission